ArriVent BioPharma Market Cap

ArriVent BioPharma has a market cap or net worth of $517.14 million as of April 26, 2024.

Market Cap

517.14M

Enterprise Value

367.07M

1-Year Change

n/a

Ranking

#2921

Market Cap Chart

Since the IPO on January 26, 2024, ArriVent BioPharma's market cap has decreased from $575.22M to $517.14M, a decrease of -10.10%. That is a compound annual growth rate of -34.75%.

Market Cap History

Date	Market Cap	% Change
Apr 26, 2024	472.00M	-0.63%
Apr 25, 2024	475.00M	1.56%
Apr 24, 2024	467.70M	-2.99%
Apr 23, 2024	482.10M	-0.80%
Apr 22, 2024	486.00M	2.57%
Apr 19, 2024	473.80M	-
Apr 18, 2024	473.80M	-3.37%
Apr 17, 2024	490.30M	-4.52%
Apr 16, 2024	513.50M	-1.19%
Apr 15, 2024	519.70M	0.66%
Apr 12, 2024	516.30M	-4.41%
Apr 11, 2024	540.10M	2.19%
Apr 10, 2024	528.50M	-0.23%
Apr 9, 2024	529.70M	-0.92%
Apr 8, 2024	534.60M	-5.21%
Apr 5, 2024	564.00M	0.82%
Apr 4, 2024	559.40M	0.99%
Apr 3, 2024	553.90M	0.67%
Apr 2, 2024	550.20M	-1.70%
Apr 1, 2024	559.70M	2.53%
Mar 28, 2024	545.90M	-0.78%
Mar 27, 2024	550.20M	1.12%
Mar 26, 2024	544.10M	4.96%
Mar 25, 2024	518.40M	-7.23%
Mar 22, 2024	558.80M	0.40%

View and export this data all the way back to 2024. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
Talkspace	529.51M
Prime Medicine	528.69M
Cabaletta Bio	524.21M
Calliditas Therapeutics AB (publ)	523.97M
OmniAb	522.38M
Phibro Animal Health	516.83M
Absci	516.79M
CureVac	516.05M

Market Cap Rankings